Inflammatory disorders of male genital organs, not elsewhere classified

N14_INFLAMALEGEN

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only males

172961

diagram downward connector

Check conditions None

172961

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 N49
Hospital discharge: ICD-9 6080|6084
Hospital discharge: ICD-8 607[4-5]
Cause of death: ICD-10 N49
Cause of death: ICD-9 6080|6084
Cause of death: ICD-8 607[4-5]

2 out of 7 registries used, show all original rules.

364

diagram downward connector

Check minimum number of events None

364

diagram downward connector

Include endpoints None

364

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

357

diagram downward connector
N14_INFLAMALEGEN

Control definitions

Control exclude N14_MALEGEN

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 N40-N51
Name in latin Morbositates inflammatoriae organorum genitalium masculinorum non alibi classificatae

Summary Statistics

Key figures

All Female Male
Number of individuals 357 - 357
Unadjusted prevalence (%) 0.09 - 0.21
Mean age at first event (years) 51.74 - 51.74

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.22 [0.45, 3.30] 6.9e-1 78
15 years 0.01 0.67 [0.27, 1.69] 4.0e-1 22
5 years 0.00 3.07 [1.47, 6.40] 2.8e-3 28
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: N14_INFLAMALEGEN – Inflammatory disorders of male genital organs, not elsewhere classified
GWS hits: 1

Survival analyses between endpoints

Plot

before Inflammatory disorders of male genital organs, not elsewhere classified
after Inflammatory disorders of male genital organs, not elsewhere classified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Inflammatory disorders of male genital organs, not elsewhere classified

Endpoint not on priority list, no data to show.